Wound Irrigation Systems Market Analysis, Research, Review, Applications and Forecast to 2032

 The global Wound Irrigation Systems Market is expected to be worth US$ 267.6 million by the end of 2022, and to grow at a 2.6% CAGR from 2022 to 2032. By 2032, the market is expected to be worth US$ 347.3 billion. In terms of product, acute wounds lead the wound irrigation systems market, accounting for approximately 58.2% in 2021.

To learn more about this report: https://www.futuremarketinsights.com/reports/wound-irrigation-system-market

Medical complications arising due to infections such as surgical site infection (SSI)- a wound infection with microbes, mainly bacteria, within 30 days of a surgical procedure- often carry a high risk of mortality and morbidity, specifically in oncological settings. SSI is one of the most common nosocomial infections and its management further burdens the healthcare system financially. One of the more reliable and effective prevention methods for SSI infection is wound irrigation.

The wound irrigation system is much preferable to swabbing or washing as it includes the flushing of the surgical incision with a solution that reduces the bacterial burden, and physically eradicates cell debris and trapped fluids.

Moreover, wound irrigation systems ensure the delivery of a regulated and stable pressure which is a primary requirement for effective wound care management. This feature coupled with much recent progress made in the design and production of new wound irrigation systems is presenting manufacturers with lucrative opportunities at the international level. The rising adoption of negative pressure wound therapy is spearheading the growth of wound irrigation systems.

The emergence of simultaneous wound irrigation technology has led to a surge in the demand for negative pressure wound therapy. These instruments supply a constant flow for the irrigant to the wound site directly from a wound irrigation delivery bag. The irrigant then exits the wound, carrying cellular debris from the wound into the negative pressure wound therapy device canister.

The use of these systems encourages the removal of bioburden and debris in the wound, eventually converting to positive procedural outcomes. Besides, other related benefits of wound irrigation systems are better patient compliance, quicker wound healing, and lower frequency of dressing changes, which in turn, promote cost savings and decrease workload within a hospital setting. All of these factors foster an environment of growth for the wound irrigation system market over the forecast period.

“Rising demand for new and innovative medical solutions for acute and chronic wound treatment will likely spur the growth of the wound irrigation system market over the forecast period,” says an FMI analyst.  

Wound flushing systems is the process of flushing out debris, bacteria, and other contaminants from a wound using a liquid solution. It is an important step in wound care and is often done using wound irrigation systems.

Key Takeaways:

  • Heightened usage of wound irrigation saline for wound treatment is boosting the market prospects.
  • Preference for traditional wound care by healthcare practitioners may hamper the market growth.
  • The U.S. market is predicted to grow at 1.7% CAGR over the assessment period.
  • Independent clinical practices to drive the market growth in Germany.
  • Battery-operated wound irrigation kits to gain popularity over the forecast period.
  • Increasing occurrence of acute wounds to drive the overall market growth.

Competitive Landscape 

  • Zimmer Biomet
  • Stryker Corporation
  • Centurion Medical Products
  • BSN Medical
  • Cooper Surgical Inc.
  • C. R. Bard, Inc.
  • Medtronic Plc.
  • Bionix
  • Westmed, Inc.
  • Becton, Dickinson, and Company

Key Segments Covered in Wound Irrigation Systems Market

By Product:

  • Manual Operated
    • Syringe Based
    • Spray Based
    • Nozzle Based
  • Battery Operated

By Wound:

  • Acute Wounds
    • Surgical Wounds
    • Traumatic Wounds
    • Burns
  • Chronic Wounds
    • Venous Ulcers
    • Pressure Ulcers
    • Diabetic Foot Ulcers
    • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long-Term Care Centers
  • Home Care Centers

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more